Medical devices

Our company is located in Antwerp and develops and commercializes medical devices. We have two devices in our portfolio. Colli-pee allows to collect first fraction urine and is CE marked and commercially available. Vax-ID is an innovative intradermal injection device, enabling painless, user-friendly and dose-sparing intradermal drug administration.

As we are always looking to expand our business internationally, we welcome potential partners who have experience in working with innovative medical devices. The potential partner is an Israeli company that will represent us (no distributor).

(1) Colli-Pee™, a sampling platform that offers new possibilities to developers and manufacturers of diagnostic tests. It also brings new opportunities to organizations that support or run screening programs.

Colli-Pee™, a patented, CE-labelled and FDA-listed device enables user-friendly and standardized collection of first-void urine by all genders. This highly concentrated urine allows improved detection of urinary biomarkers for early stage diagnosis and monitoring of urological and systemic cancers. As urine is an easy accessible and non-invasive sample, market leaders are discovering the advantages of Colli-Pee™ and start to integrate the medical device into their diagnostic kit, offering better and robust results while adding comfort to the patient and the medical staff.

(2) VAX-ID™, a drug delivery platform that operates with an unprecedented ease-of-use in combination with an improved accuracy offering new possibilities to vaccine developers and manufacturers as well as organizations that support or run vaccination programs.